Dekker C. Jeffrey 4
4 · ARCA biopharma, Inc. · Filed Dec 16, 2021
Insider Transaction Report
Form 4
Dekker C. Jeffrey
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-14+17,700→ 17,700 totalExercise: $2.29Exp: 2031-12-14→ Common Stock (17,700 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan (the Plan), vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.